Cargando…
A Highly Sensitive Biomarker of Type II Collagen C-Terminal Pro-Peptide Associated with Cartilage Formation
The type II collagen C-terminal pro-peptide is one of the most abundant polypeptides in cartilage. The purpose of this study was to develop a competitive chemiluminescence enzyme-linked immunosorbent assay, CALC2, targeting this pro-peptide as a marker of cartilage formation. Technical assay paramet...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9820484/ https://www.ncbi.nlm.nih.gov/pubmed/36613894 http://dx.doi.org/10.3390/ijms24010454 |
_version_ | 1784865476013195264 |
---|---|
author | Port, Helena Bay-Jensen, Anne-Christine He, Yi Karsdal, Morten A. Gantzel, Thorbjørn Thudium, Christian S. Holm Nielsen, Signe |
author_facet | Port, Helena Bay-Jensen, Anne-Christine He, Yi Karsdal, Morten A. Gantzel, Thorbjørn Thudium, Christian S. Holm Nielsen, Signe |
author_sort | Port, Helena |
collection | PubMed |
description | The type II collagen C-terminal pro-peptide is one of the most abundant polypeptides in cartilage. The purpose of this study was to develop a competitive chemiluminescence enzyme-linked immunosorbent assay, CALC2, targeting this pro-peptide as a marker of cartilage formation. Technical assay parameters were evaluated. CALC2 level was measured after in vitro cleavage of recombinant type II collagen with bone morphogenetic protein-1 (BMP-1) and treatment of ex vivo human osteoarthritis (OA) cartilage explant model (HEX) with insulin-like growth factor-1 (IGF-1). Serum CALC2 levels were assessed in 18 patients with rheumatoid arthritis (RA), 19 patients with ankylosing spondylitis (AS), and 18 age- and sex-matched controls in cohort 1 and 8 patients with OA and 14 age- and sex-matched controls in cohort 2. Type II collagen cleavage with BMP-1 increased the CALC2 level. IGF-1 treatment increased the CALC2 levels in HEX compared with the untreated explants (p < 0.05). Results were confirmed using Western blot analysis. CALC2 levels were decreased in the patients with RA and AS compared with the healthy controls (p = 0.01 and p = 0.02, respectively). These findings indicate that CALC2 may be a novel biomarker of type II collagen formation. However, further preclinical and clinical studies are required to validate these findings. |
format | Online Article Text |
id | pubmed-9820484 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-98204842023-01-07 A Highly Sensitive Biomarker of Type II Collagen C-Terminal Pro-Peptide Associated with Cartilage Formation Port, Helena Bay-Jensen, Anne-Christine He, Yi Karsdal, Morten A. Gantzel, Thorbjørn Thudium, Christian S. Holm Nielsen, Signe Int J Mol Sci Article The type II collagen C-terminal pro-peptide is one of the most abundant polypeptides in cartilage. The purpose of this study was to develop a competitive chemiluminescence enzyme-linked immunosorbent assay, CALC2, targeting this pro-peptide as a marker of cartilage formation. Technical assay parameters were evaluated. CALC2 level was measured after in vitro cleavage of recombinant type II collagen with bone morphogenetic protein-1 (BMP-1) and treatment of ex vivo human osteoarthritis (OA) cartilage explant model (HEX) with insulin-like growth factor-1 (IGF-1). Serum CALC2 levels were assessed in 18 patients with rheumatoid arthritis (RA), 19 patients with ankylosing spondylitis (AS), and 18 age- and sex-matched controls in cohort 1 and 8 patients with OA and 14 age- and sex-matched controls in cohort 2. Type II collagen cleavage with BMP-1 increased the CALC2 level. IGF-1 treatment increased the CALC2 levels in HEX compared with the untreated explants (p < 0.05). Results were confirmed using Western blot analysis. CALC2 levels were decreased in the patients with RA and AS compared with the healthy controls (p = 0.01 and p = 0.02, respectively). These findings indicate that CALC2 may be a novel biomarker of type II collagen formation. However, further preclinical and clinical studies are required to validate these findings. MDPI 2022-12-27 /pmc/articles/PMC9820484/ /pubmed/36613894 http://dx.doi.org/10.3390/ijms24010454 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Port, Helena Bay-Jensen, Anne-Christine He, Yi Karsdal, Morten A. Gantzel, Thorbjørn Thudium, Christian S. Holm Nielsen, Signe A Highly Sensitive Biomarker of Type II Collagen C-Terminal Pro-Peptide Associated with Cartilage Formation |
title | A Highly Sensitive Biomarker of Type II Collagen C-Terminal Pro-Peptide Associated with Cartilage Formation |
title_full | A Highly Sensitive Biomarker of Type II Collagen C-Terminal Pro-Peptide Associated with Cartilage Formation |
title_fullStr | A Highly Sensitive Biomarker of Type II Collagen C-Terminal Pro-Peptide Associated with Cartilage Formation |
title_full_unstemmed | A Highly Sensitive Biomarker of Type II Collagen C-Terminal Pro-Peptide Associated with Cartilage Formation |
title_short | A Highly Sensitive Biomarker of Type II Collagen C-Terminal Pro-Peptide Associated with Cartilage Formation |
title_sort | highly sensitive biomarker of type ii collagen c-terminal pro-peptide associated with cartilage formation |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9820484/ https://www.ncbi.nlm.nih.gov/pubmed/36613894 http://dx.doi.org/10.3390/ijms24010454 |
work_keys_str_mv | AT porthelena ahighlysensitivebiomarkeroftypeiicollagencterminalpropeptideassociatedwithcartilageformation AT bayjensenannechristine ahighlysensitivebiomarkeroftypeiicollagencterminalpropeptideassociatedwithcartilageformation AT heyi ahighlysensitivebiomarkeroftypeiicollagencterminalpropeptideassociatedwithcartilageformation AT karsdalmortena ahighlysensitivebiomarkeroftypeiicollagencterminalpropeptideassociatedwithcartilageformation AT gantzelthorbjørn ahighlysensitivebiomarkeroftypeiicollagencterminalpropeptideassociatedwithcartilageformation AT thudiumchristians ahighlysensitivebiomarkeroftypeiicollagencterminalpropeptideassociatedwithcartilageformation AT holmnielsensigne ahighlysensitivebiomarkeroftypeiicollagencterminalpropeptideassociatedwithcartilageformation AT porthelena highlysensitivebiomarkeroftypeiicollagencterminalpropeptideassociatedwithcartilageformation AT bayjensenannechristine highlysensitivebiomarkeroftypeiicollagencterminalpropeptideassociatedwithcartilageformation AT heyi highlysensitivebiomarkeroftypeiicollagencterminalpropeptideassociatedwithcartilageformation AT karsdalmortena highlysensitivebiomarkeroftypeiicollagencterminalpropeptideassociatedwithcartilageformation AT gantzelthorbjørn highlysensitivebiomarkeroftypeiicollagencterminalpropeptideassociatedwithcartilageformation AT thudiumchristians highlysensitivebiomarkeroftypeiicollagencterminalpropeptideassociatedwithcartilageformation AT holmnielsensigne highlysensitivebiomarkeroftypeiicollagencterminalpropeptideassociatedwithcartilageformation |